Effect of Gemigliptin Versus Glimepiride on Cardiac Diastolic Function in Patients With Type 2 Diabetes

NCT05663736 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Ejection Fraction

Interventions

DRUG: Gemigliptin
DRUG: Glimepiride

Sponsor

Seoul National University Bundang Hospital